Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDA MDI HFO versus HFA equivalence study in adults with asthma
CTR20244788Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, salbutamol in asthma, sponsored by AstraZeneca. Started Jan 2025; status: completed.
02
Drugs
budesonidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20244788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244788.